Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.42 |
| ▸ | HMOX1 | P09601 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.40 |
| ▸ | QPCT | Q16769 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1369052 | 0.83 | — | — | |
| SCHEMBL14738593 | 0.83 | — | — | |
| Bromide SCHEMBL18191796 | 0.82 | FDPS (0.47) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL18028285 | 0.80 | FDPS (0.46) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL21316528 | 0.80 | FDPS (0.46) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL25067258 | 0.79 | FDPS (0.48) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL12251321 | 0.79 | TBXAS1 (0.50) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 | |
| SCHEMBL28961361 | 0.79 | — | — | |
| SCHEMBL171211 | 0.79 | — | — | |
| SCHEMBL22710046 | 0.78 | FDPS (0.44) | FDPSCYP19A1TBXAS1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200368254-A1 | LIPID-LIKE NANOCOMPLEXES AND USES THEREOF | TRUSTEES OF TUFTS COLLEGE | 2020-11-26 | — | — | US | disclosed |
| WO-2012014898-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学工業株式会社 (JP) | 2012-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200368254-A1 | LIPID-LIKE NANOCOMPLEXES AND USES THEREOF | APOB, LDLR, LIPA | FDPS 2276/4885CYP19A1 3360/4885TBXAS1 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.